RADIANT PRIME RECOVERY (813)384-8050 contact@RadiantPrimeRecovery.com

  • Home
  • About Us
  • Our Services
    • Quit Opioids
    • Quit Alcohol
    • Mental Health
    • Dual Diagnosis
    • Targeted Case Management
  • Resources
  • Locations
    • ARIZONA
    • FLORIDA
    • KENTUCKY
  • Drug Testing
  • More
    • Home
    • About Us
    • Our Services
      • Quit Opioids
      • Quit Alcohol
      • Mental Health
      • Dual Diagnosis
      • Targeted Case Management
    • Resources
    • Locations
      • ARIZONA
      • FLORIDA
      • KENTUCKY
    • Drug Testing
  • Home
  • About Us
  • Our Services
    • Quit Opioids
    • Quit Alcohol
    • Mental Health
    • Dual Diagnosis
    • Targeted Case Management
  • Resources
  • Locations
    • ARIZONA
    • FLORIDA
    • KENTUCKY
  • Drug Testing

ADDICTION BEHIND BARS

Roughly 60% of Inmates have a Substance Use Disorder

Substance Use Disorder is a major driver of incarceration in the United States. Inmates with untreated addiction face a high risk of relapse and reoffending upon release, especially in the first few weeks - at time when the risk of overdose death is up to 129 times higher than the general population. In fact, overdose is the leading cause of death among people returning to their communities after being in jail or prison. When people with addiction leave prison or jail and return to their communities, their tolerance level has diminished during incarceration. Returning to drug use, even one time, can lead to a fatal overdose. 


It remains a common belief that simply stopping someone from taking drugs while in jail or prison is an effective approach to treatment. But this belief is inaccurate and dangerous. The Food and Drug Administration has approved three medications for opioid use disorder: Methadone, Buprenorphine, and Naltrexone. All three are effective, safe, and life-saving. But they are drastically underused, particularly in criminal justice settings. 

Those with Addiction Need Access to Treatment

MAT programs in jails and prisons have successfully reduced the risk of overdose among participants

Studies show that people who receive medication for treatment of substance use disorder while in jail or prison are less likely to return to drug use and more likely to continue with treatment after being released from incarceration. Plus, the overdose death rates have been shown to be decreased by 30% in communities with jails/prisons that utilize MAT programs. PLUS, they are less likely to re-offend and successfuly re-enter society. 


Jails and prisons are increasingly providing medication for addiction treatment (MAT), an evidence-based approach for treating addiction, particularly opioid use disorder. However, providing MAT in jail settings presents unique challenges compared to prisons, as lengths of stay can be short and unpredictable. 

Partner with Radiant Prime Recovery for Continuity of Care

Let's Make Our Communities Safe Again

At Radiant Prime Recovery, we understand the critical importance of supporting individuals with substance use disorders during and after incarceration. Our Executive Clinical Director has spent the past six years working in correctional facilities throughout the country - implementing detox programs, MAT programs, and discharge planning services to ensure patients continue their recovery journey upon release. 


Through our secure telehealth and coordinated care, we offer: 

  • Initiation or Continuation of Medication-Assisted Treatment
  • Individualized Discharge Planning 
  • Seamless Transition into Outpatient Care, with next day appointments available 
  • Targeted Case Management Services 


Break the Chains of Addiction...Stop the Cycle

INTERESTED IN PARTNERING WITH US?

Call Radiant Prime RecoveryEMAIL RADIANT PRIME RECOVERY

Connect With Us

Copyright © 2025 Radiant Prime Recovery - All Rights Reserved.

  • ABOUT
  • Privacy Policy
  • Terms & Conditions
  • FAQ
  • MEET OUR TEAM
  • Correctional Facilities

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept